iCAD, Inc. (ICAD)
USD 1.74
(-5.95%)
USD 1.74
(-5.95%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.84 Million USD | 45.53% |
| 2022 | -13.65 Million USD | -21.44% |
| 2021 | -11.24 Million USD | 36.14% |
| 2020 | -17.61 Million USD | -29.95% |
| 2019 | -13.55 Million USD | -50.28% |
| 2018 | -9.01 Million USD | 36.75% |
| 2017 | -14.25 Million USD | -41.16% |
| 2016 | -10.09 Million USD | 68.88% |
| 2015 | -32.44 Million USD | -3115.76% |
| 2014 | -1 Million USD | 86.74% |
| 2013 | -7.6 Million USD | 18.84% |
| 2012 | -9.37 Million USD | 75.06% |
| 2011 | -37.58 Million USD | -503.91% |
| 2010 | -6.22 Million USD | -216.32% |
| 2009 | -1.96 Million USD | -145.17% |
| 2008 | 4.35 Million USD | 383.14% |
| 2007 | -1.53 Million USD | 76.82% |
| 2006 | -6.63 Million USD | -39.5% |
| 2005 | -4.75 Million USD | -474.51% |
| 2004 | -828.26 Thousand USD | 89.9% |
| 2003 | -8.19 Million USD | 12.95% |
| 2002 | -9.41 Million USD | -259.37% |
| 2001 | -2.62 Million USD | -43.4% |
| 2000 | -1.82 Million USD | 54.31% |
| 1999 | -4 Million USD | -17.65% |
| 1998 | -3.4 Million USD | -325.0% |
| 1997 | -800 Thousand USD | 86.89% |
| 1996 | -6.1 Million USD | -15.09% |
| 1995 | -5.3 Million USD | -688.89% |
| 1994 | 900 Thousand USD | 212.5% |
| 1993 | -800 Thousand USD | -121.05% |
| 1992 | 3.8 Million USD | 176.0% |
| 1991 | -5 Million USD | -117.39% |
| 1990 | -2.3 Million USD | 34.29% |
| 1989 | -3.5 Million USD | 33.96% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.73 Million USD | -42.31% |
| 2024 Q1 | -1.22 Million USD | -189.72% |
| 2023 FY | -7.43 Million USD | 45.53% |
| 2023 Q1 | -3.77 Million USD | -22.07% |
| 2023 Q2 | -1.75 Million USD | 53.68% |
| 2023 Q3 | -1.37 Million USD | 21.49% |
| 2023 Q4 | 1.36 Million USD | 199.13% |
| 2022 Q3 | -3.83 Million USD | -22.87% |
| 2022 FY | -13.65 Million USD | -21.44% |
| 2022 Q1 | -3.54 Million USD | 14.5% |
| 2022 Q2 | -3.12 Million USD | 11.93% |
| 2022 Q4 | -3.09 Million USD | 19.32% |
| 2021 Q4 | -4.14 Million USD | -90.53% |
| 2021 Q2 | -3.28 Million USD | -99.63% |
| 2021 FY | -11.24 Million USD | 36.14% |
| 2021 Q1 | -1.64 Million USD | -2.5% |
| 2021 Q3 | -2.17 Million USD | 33.66% |
| 2020 FY | -17.61 Million USD | -29.95% |
| 2020 Q2 | -2.39 Million USD | 79.7% |
| 2020 Q1 | -11.81 Million USD | -252.81% |
| 2020 Q4 | -1.6 Million USD | 10.8% |
| 2020 Q3 | -1.79 Million USD | 25.06% |
| 2019 Q1 | -3.71 Million USD | -11.15% |
| 2019 Q3 | -2.95 Million USD | 16.26% |
| 2019 Q2 | -3.53 Million USD | 5.03% |
| 2019 FY | -13.55 Million USD | -50.28% |
| 2019 Q4 | -3.34 Million USD | -13.26% |
| 2018 Q4 | -3.34 Million USD | -144.98% |
| 2018 FY | -9.01 Million USD | 36.75% |
| 2018 Q1 | -3.28 Million USD | 22.53% |
| 2018 Q2 | -1.02 Million USD | 68.7% |
| 2018 Q3 | -1.36 Million USD | -32.91% |
| 2017 FY | -14.25 Million USD | -41.16% |
| 2017 Q1 | -457 Thousand USD | 86.22% |
| 2017 Q2 | -2.63 Million USD | -475.71% |
| 2017 Q4 | -4.23 Million USD | 38.92% |
| 2017 Q3 | -6.93 Million USD | -163.51% |
| 2016 FY | -10.09 Million USD | 68.88% |
| 2016 Q3 | -2.66 Million USD | -69.21% |
| 2016 Q1 | -2.53 Million USD | -5.45% |
| 2016 Q2 | -1.57 Million USD | 37.82% |
| 2016 Q4 | -3.31 Million USD | -24.43% |
| 2015 Q2 | -27.78 Million USD | -1396.28% |
| 2015 Q4 | -2.4 Million USD | -497.51% |
| 2015 Q1 | -1.85 Million USD | -1834.38% |
| 2015 FY | -32.44 Million USD | -3115.76% |
| 2015 Q3 | -402 Thousand USD | 98.55% |
| 2014 Q2 | -997 Thousand USD | -424.74% |
| 2014 FY | -1 Million USD | 86.74% |
| 2014 Q4 | -96 Thousand USD | -135.04% |
| 2014 Q1 | -190 Thousand USD | 95.69% |
| 2014 Q3 | 274 Thousand USD | 127.48% |
| 2013 Q4 | -4.41 Million USD | -648.73% |
| 2013 FY | -7.6 Million USD | 18.84% |
| 2013 Q3 | -589 Thousand USD | 68.7% |
| 2013 Q2 | -1.88 Million USD | -158.87% |
| 2013 Q1 | -727 Thousand USD | 73.09% |
| 2012 Q1 | -2.26 Million USD | 31.6% |
| 2012 FY | -9.37 Million USD | 75.06% |
| 2012 Q4 | -2.7 Million USD | -84.44% |
| 2012 Q3 | -1.46 Million USD | 50.22% |
| 2012 Q2 | -2.94 Million USD | -29.99% |
| 2011 Q4 | -3.31 Million USD | 86.75% |
| 2011 FY | -37.58 Million USD | -503.91% |
| 2011 Q1 | -4.2 Million USD | -44.33% |
| 2011 Q2 | -5.09 Million USD | -21.23% |
| 2011 Q3 | -24.98 Million USD | -390.54% |
| 2010 Q2 | -736.11 Thousand USD | 37.86% |
| 2010 Q1 | -1.18 Million USD | -473.22% |
| 2010 Q3 | -1.39 Million USD | -89.18% |
| 2010 Q4 | -2.91 Million USD | -109.01% |
| 2010 FY | -6.22 Million USD | -216.32% |
| 2009 Q2 | -1.39 Million USD | -40.13% |
| 2009 Q3 | 112.75 Thousand USD | 108.06% |
| 2009 Q4 | 317.39 Thousand USD | 181.49% |
| 2009 Q1 | -998.52 Thousand USD | -411.19% |
| 2009 FY | -1.96 Million USD | -145.17% |
| 2008 Q3 | 2.09 Million USD | -12.24% |
| 2008 Q4 | 320.86 Thousand USD | -84.68% |
| 2008 Q1 | -445.85 Thousand USD | -184.91% |
| 2008 Q2 | 2.38 Million USD | 635.29% |
| 2008 FY | 4.35 Million USD | 383.14% |
| 2007 Q2 | -839.61 Thousand USD | -51.57% |
| 2007 FY | -1.53 Million USD | 76.82% |
| 2007 Q4 | 525.06 Thousand USD | 178.36% |
| 2007 Q3 | -670.04 Thousand USD | 20.2% |
| 2007 Q1 | -553.93 Thousand USD | 59.84% |
| 2006 Q4 | -1.37 Million USD | -26.02% |
| 2006 Q3 | -1.09 Million USD | 57.22% |
| 2006 Q2 | -2.55 Million USD | -59.31% |
| 2006 FY | -6.63 Million USD | -39.5% |
| 2006 Q1 | -1.6 Million USD | 8.44% |
| 2005 Q1 | 611.49 Thousand USD | -2.39% |
| 2005 Q4 | -1.75 Million USD | 31.56% |
| 2005 FY | -4.75 Million USD | -474.51% |
| 2005 Q3 | -2.56 Million USD | -136.5% |
| 2005 Q2 | -1.08 Million USD | -277.21% |
| 2004 Q4 | 626.48 Thousand USD | 86.82% |
| 2004 Q3 | 335.35 Thousand USD | 621.84% |
| 2004 Q2 | 46.45 Thousand USD | 102.45% |
| 2004 FY | -828.26 Thousand USD | 89.9% |
| 2004 Q1 | -1.89 Million USD | -19.13% |
| 2003 Q1 | 76.55 Thousand USD | -25.68% |
| 2003 Q4 | -1.59 Million USD | 70.45% |
| 2003 FY | -8.19 Million USD | 12.95% |
| 2003 Q3 | -5.39 Million USD | -319.83% |
| 2003 Q2 | -1.28 Million USD | -1778.65% |
| 2002 Q4 | 103 Thousand USD | 106.28% |
| 2002 Q2 | -7.35 Million USD | -1312.24% |
| 2002 FY | -9.41 Million USD | -259.37% |
| 2002 Q1 | -521.12 Thousand USD | 17.94% |
| 2002 Q3 | -1.64 Million USD | 77.71% |
| 2001 Q2 | -797.94 Thousand USD | -24.76% |
| 2001 FY | -2.62 Million USD | -43.4% |
| 2001 Q1 | -639.59 Thousand USD | 22.95% |
| 2001 Q4 | -635.03 Thousand USD | -15.84% |
| 2001 Q3 | -548.2 Thousand USD | 31.3% |
| 2000 Q2 | -257.5 Thousand USD | 54.38% |
| 2000 Q4 | -830.05 Thousand USD | -372.62% |
| 2000 Q3 | -175.62 Thousand USD | 31.8% |
| 2000 Q1 | -564.46 Thousand USD | -41.12% |
| 2000 FY | -1.82 Million USD | 54.31% |
| 1999 FY | -4 Million USD | -17.65% |
| 1999 Q4 | -400 Thousand USD | 33.33% |
| 1999 Q2 | -300 Thousand USD | 88.89% |
| 1999 Q3 | -600 Thousand USD | -100.0% |
| 1999 Q1 | -2.7 Million USD | -285.71% |
| 1998 Q1 | -1.1 Million USD | 15.38% |
| 1998 FY | -3.4 Million USD | -325.0% |
| 1998 Q3 | -800 Thousand USD | 0.0% |
| 1998 Q4 | -700 Thousand USD | 12.5% |
| 1998 Q2 | -800 Thousand USD | 27.27% |
| 1997 Q4 | -1.3 Million USD | -116.67% |
| 1997 Q1 | -1.1 Million USD | -37.5% |
| 1997 FY | -800 Thousand USD | 86.89% |
| 1997 Q2 | 2.2 Million USD | 300.0% |
| 1997 Q3 | -600 Thousand USD | -127.27% |
| 1996 Q4 | -800 Thousand USD | 52.94% |
| 1996 FY | -6.1 Million USD | -15.09% |
| 1996 Q3 | -1.7 Million USD | -41.67% |
| 1996 Q2 | -1.2 Million USD | 47.83% |
| 1996 Q1 | -2.3 Million USD | -53.33% |
| 1995 Q4 | -1.5 Million USD | -25.0% |
| 1995 FY | -5.3 Million USD | -688.89% |
| 1995 Q3 | -1.2 Million USD | 57.14% |
| 1995 Q2 | -2.8 Million USD | -1500.0% |
| 1995 Q1 | 200 Thousand USD | -75.0% |
| 1994 Q2 | 200 Thousand USD | 140.0% |
| 1994 Q3 | 400 Thousand USD | 100.0% |
| 1994 Q4 | 800 Thousand USD | 100.0% |
| 1994 FY | 900 Thousand USD | 212.5% |
| 1994 Q1 | -500 Thousand USD | 54.55% |
| 1993 FY | -800 Thousand USD | -121.05% |
| 1993 Q3 | -900 Thousand USD | -325.0% |
| 1993 Q2 | 400 Thousand USD | -50.0% |
| 1993 Q1 | 800 Thousand USD | -60.0% |
| 1993 Q4 | -1.1 Million USD | -22.22% |
| 1992 Q4 | 2 Million USD | 53.85% |
| 1992 Q2 | 800 Thousand USD | 366.67% |
| 1992 Q1 | -300 Thousand USD | 57.14% |
| 1992 FY | 3.8 Million USD | 176.0% |
| 1992 Q3 | 1.3 Million USD | 62.5% |
| 1991 FY | -5 Million USD | -117.39% |
| 1991 Q2 | -1.4 Million USD | -7.69% |
| 1991 Q1 | -1.3 Million USD | 62.86% |
| 1991 Q3 | -1.6 Million USD | -14.29% |
| 1991 Q4 | -700 Thousand USD | 56.25% |
| 1990 Q4 | -3.5 Million USD | -600.0% |
| 1990 FY | -2.3 Million USD | 34.29% |
| 1990 Q3 | 700 Thousand USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 FY | -3.5 Million USD | 33.96% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 92.134% |
| BrainsWay Ltd. | -4.19 Million USD | -15.487% |
| Cerus Corporation | -37.48 Million USD | 87.071% |
| Envoy Medical, Inc. | -29.9 Million USD | 83.794% |
| electroCore, Inc. | -18.83 Million USD | 74.265% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 45.232% |
| IceCure Medical Ltd | -14.65 Million USD | 66.919% |
| Inogen, Inc. | -102.44 Million USD | 95.269% |
| OrthoPediatrics Corp. | -20.97 Million USD | 76.89% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 90.797% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 64.737% |
| MaxCyte, Inc. | -37.92 Million USD | 87.219% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 59.13% |
| Nexalin Technology, Inc. | -4.64 Million USD | -4.266% |
| Orthofix Medical Inc. | -151.39 Million USD | 96.798% |
| PAVmed Inc | -64.17 Million USD | 92.447% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 90.762% |
| RxSight, Inc. | -48.6 Million USD | 90.028% |
| Sight Sciences, Inc. | -55.54 Million USD | 91.274% |
| SI-BONE, Inc. | -43.33 Million USD | 88.815% |
| TELA Bio, Inc. | -46.66 Million USD | 89.613% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 90.213% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 64.316% |
| Acutus Medical, Inc. | -81.66 Million USD | 94.065% |
| Talis Biomedical Corporation | -62 Million USD | 92.183% |
| Spectral AI, Inc. | -20.85 Million USD | 76.757% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 92.025% |
| CVRx, Inc. | -41.19 Million USD | 88.235% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 857.112% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 55.757% |
| Bioventus Inc. | -156.23 Million USD | 96.898% |
| Venus Concept Inc. | -37.25 Million USD | 86.988% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 91.79% |
| LivaNova PLC | 17.54 Million USD | 127.625% |
| 908 Devices Inc. | -36.39 Million USD | 86.684% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 97.403% |
| Nemaura Medical Inc. | -14.14 Million USD | 65.73% |
| NeuroPace, Inc. | -32.95 Million USD | 85.293% |
| LENSAR, Inc. | -14.38 Million USD | 66.3% |
| Apyx Medical Corporation | -18.71 Million USD | 74.098% |
| Cutera, Inc. | -162.83 Million USD | 97.023% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 55.245% |
| BioSig Technologies, Inc. | -29.04 Million USD | 83.31% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 94.137% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 78.057% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 107.155% |
| Axonics, Inc. | -6.08 Million USD | 20.384% |
| Outset Medical, Inc. | -172.79 Million USD | 97.195% |
| IRIDEX Corporation | -9.57 Million USD | 49.352% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 95.423% |
| IRadimed Corporation | 17.19 Million USD | 128.192% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 41.206% |
| INVO Bioscience, Inc. | -8.03 Million USD | 39.674% |
| Telesis Bio, Inc. | -47.72 Million USD | 89.844% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 147.32% |
| Varex Imaging Corporation | -47.7 Million USD | 89.839% |
| Quipt Home Medical Corp. | -2.78 Million USD | -74.102% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 57.053% |
| Pulmonx Corporation | -60.84 Million USD | 92.034% |
| Dynatronics Corporation | -2.69 Million USD | -79.67% |
| Modular Medical, Inc. | -17.47 Million USD | 72.255% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 57.434% |
| Semler Scientific, Inc. | 20.58 Million USD | 123.549% |
| InMode Ltd. | 197.91 Million USD | 102.449% |
| Bruker Corporation | 427.2 Million USD | 101.135% |
| Cytosorbents Corporation | -28.5 Million USD | 82.997% |
| DexCom, Inc. | 541.5 Million USD | 100.895% |
| Align Technology, Inc. | 445.05 Million USD | 101.089% |
| Viveve Medical, Inc. | -22.02 Million USD | 77.995% |
| ZimVie Inc. | -393.28 Million USD | 98.768% |
| Movano Inc. | -29.28 Million USD | 83.448% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 60.1% |
| Nexalin Technology, Inc. | -4.64 Million USD | -4.266% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 857.112% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 97.823% |
| Profound Medical Corp. | -28.56 Million USD | 83.034% |
| Insulet Corporation | 206.3 Million USD | 102.349% |
| enVVeno Medical Corporation | -23.51 Million USD | 79.389% |
| Surmodics, Inc. | -11.54 Million USD | 58.006% |
| Nuwellis, Inc. | -20.2 Million USD | 76.016% |
| Biotricity, Inc. | -14.09 Million USD | 65.61% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 96.072% |
| Aethlon Medical, Inc. | -12.2 Million USD | 60.297% |
| InspireMD, Inc. | -19.91 Million USD | 75.663% |
| PAVmed Inc. | -64.17 Million USD | 92.447% |
| BIOLASE, Inc. | -20.63 Million USD | 76.507% |
| Beyond Air, Inc. | -60.24 Million USD | 91.954% |
| FONAR Corporation | 10.56 Million USD | 145.867% |
| AxoGen, Inc. | -21.71 Million USD | 77.68% |
| Vivani Medical, Inc. | -25.65 Million USD | 81.105% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 116.998% |
| Inari Medical, Inc. | -1.63 Million USD | -196.271% |
| UFP Technologies, Inc. | 44.92 Million USD | 110.789% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 5.56% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 26.619% |
| Tenon Medical, Inc. | -15.58 Million USD | 68.892% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 68.579% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 86.282% |
| AdaptHealth Corp. | -678.89 Million USD | 99.286% |
| Sintx Technologies, Inc. | -8.25 Million USD | 41.313% |
| NanoVibronix, Inc. | -3.71 Million USD | -30.612% |
| Quanterix Corporation | -32.33 Million USD | 85.01% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 57.053% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 1099.381% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 98.42% |
| TransMedics Group, Inc. | -25.02 Million USD | 80.634% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 78.101% |
| NeuroMetrix, Inc. | -6.52 Million USD | 25.768% |
| Hyperfine, Inc. | -44.23 Million USD | 89.043% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 93.826% |
| Biomerica, Inc. | -5.97 Million USD | 18.919% |
| Bone Biologics Corporation | -8.94 Million USD | 45.836% |
| AVITA Medical, Inc. | -39.16 Million USD | 87.625% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 51.305% |
| Silk Road Medical, Inc | -55.74 Million USD | 91.305% |